DIOVANHCT
Live / Applied — Fourth extension granted (statement of use) (as of 14 Jul 2025)
What this means for you
Not registered yet, but its 12 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97122042
- Mark type
- Design + words
- Filed
- 12 Nov 2021
- Published for opposition
- 23 May 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 035 — Advertising and business services: Business administration of patient reimbursement programs, namely, programs to provide patients reimbursement for insurance co-payments for medications
- Class 036 — Insurance and financial services: Financial administration of patient reimbursement programs, namely, programs to provide patients reimbursement for insurance co-payments for medications
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 16 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2025 — SOU EXTENSION 4 GRANTED
- 14 Jul 2025 — SOU EXTENSION 4 FILED
- 14 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2025 — SOU EXTENSION 3 GRANTED
- 14 Jan 2025 — SOU EXTENSION 3 FILED
- 14 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2024 — SOU EXTENSION 2 GRANTED
- 11 Jul 2024 — SOU EXTENSION 2 FILED
- 11 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2024 — SOU EXTENSION 1 GRANTED